• About
    • About Sutro
    • Patient Resources
    • Partnerships
    • Corporate Presentation
  • Leadership
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • Technology
    • XpressCF® and XpressCF+™ Platforms
    • Antibody-Drug Conjugates and IADCs
    • Bispecific and Engineered Antibodies
    • cGMP Facility
  • Investors
    • Company Presentation
    • Stock
    • Financials
    • Governance
    • Contact IR
    • Email Alerts
  • Pipeline
  • News
    • News Releases
    • Clinical / Scientific Presentation and Publication Highlights
    • Events
    • Events Audio Replays
  • Careers and Culture
    • The Way We Work
    • Join Our Team
    • Diversity, Inclusion and Social Justice
    • Internships
    • Sutroites
  • Contact Us

Bill Newell, CEO Interviewed by Biotech 2050

by Asa Elmore | Feb 24, 2021 | Events, News

Bill Newell, CEO Interviewed by Biotech 2050 Episode 47. Next Generation Cell Free Cancer and Autoimmune Therapeutics, Bill Newell, CEO, Sutro...

Sutro Biopharma to Participate in the Cowen 41st Annual Healthcare Conference

by Asa Elmore | Feb 23, 2021 | Events, News, Press Releases

Sutro Biopharma to Participate in the Cowen 41st Annual Healthcare Conference SOUTH SAN FRANCISCO, Calif., Feb. 23, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of...

Sutro Biopharma Announces First Patient Dosed in the Dose-Expansion Study of STRO-002 in Patients with Ovarian Cancer

by Asa Elmore | Jan 21, 2021 | News, Press Releases

Sutro Biopharma Announces First Patient Dosed in the Dose-Expansion Study of STRO-002 in Patients with Ovarian Cancer SOUTH SAN FRANCISCO, Calif., Jan. 21, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing...

39th Annual JP Morgan Healthcare Conference – Presentation

by Asa Elmore | Jan 14, 2021 | Events, News, Presentations

39th Annual JP Morgan Healthcare Conference – Presentation Webcast, CLICK HERE      Download Presentation,  CLICK...

BioSpace – Sutro Biopharma Maximizes Synergy to Treat Cancer and Preserve Quality of Life

by Asa Elmore | Jan 12, 2021 | News

BioSpace – Sutro Biopharma Maximizes Synergy to Treat Cancer and Preserve Quality of Life https://www.biospace.com/article/sutro-maximizes-synergy-to-treat-cancer-and-preserve-quality-of-life/ By: Heather McKenzie Published: Jan. 12, 2021   Sutro Biopharma wants...

Sutro Biopharma to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference

by Asa Elmore | Jan 5, 2021 | Events, News, Press Releases

Sutro Biopharma to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference SOUTH SAN FRANCISCO, Calif., Jan. 5, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application...
« Older Entries

Sutro Biopharma

310 Utah Ave Suite 150
South San Francisco, CA 94080
650-392-8412

 

Map

Tweets by @sutrobio

Contact Us

General Inquires:
general@sutrobio.com
Business Inquires:
busdev@sutrobio.com
Investor Relations Inquires:
IR@sutrobio.com 
Careers:
jobs@sutrobio.com

© 2021 Sutro Biopharma, Inc. -- Privacy Policy
  • Follow
  • Follow
  • Follow